Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...

Argenx’s Unnatural Products acquisition brings a macrocyclic peptides discovery platform for developing oral peptide drugs.

Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...

Patients increasingly expect convenient, consumer-focused healthcare experiences, panelists said at the recent MedCity INVEST ...

Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical ...

Simulations do not replace human judgment: they inform it, making transparent what would otherwise remain a “black box.” EU ...

Typically, software placed on the market will undergo changes and updates after its initial release. In the case of ...

In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they are going beyond the pill in their GLP-1 strategy and responded to a question about whether they will exist ...

Midstream's Series A round was led by Valtruis, and included participation from Andreessen Horowitz (a16z), Foundry and ...

Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The ...

The FTC sent warning letters to 25 health plan marketers over potentially deceptive marketing practices, following its ...

For life science employers who offer these benefits should pay particular attention to new state laws and regulations to ...